ABBVIE INC. vs. Seres Therapeutics, Inc.
ABBVIE INC. (ABBV) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABBV | MCRB | |
|---|---|---|
| Market Cap | $434.78 billion | $48.41 million |
| Revenue (TTM) | — | $1.88 million |
| Net Income (TTM) | — | $-22,463,000 |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | MCRB | |
|---|---|---|
| Price / Book | — | 1.40 |
| Price / Sales | — | 25.71 |
ABBV and MCRB split the valuation factors evenly.
Profitability
| ABBV | MCRB | |
|---|---|---|
| Net Margin | — | -1192.94% |
| Return on Equity | — | -65.05% |
ABBV and MCRB split the profitability factors evenly.
Dividend
| ABBV | MCRB | |
|---|---|---|
| Dividend Yield | 2.81% | — |
ABBV and MCRB split the dividend factors evenly.
Risk & Sentiment
| ABBV | MCRB | |
|---|---|---|
| Short Interest | 0.85% | 49.60% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, MCRB overview, MCRB financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.